1. Home
  2. SSBI vs ONCY Comparison

SSBI vs ONCY Comparison

Compare SSBI & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SSBI

Summit State Bank

HOLD

Current Price

$13.02

Market Cap

86.7M

Sector

Finance

ML Signal

HOLD

Logo Oncolytics Biotech Inc.

ONCY

Oncolytics Biotech Inc.

HOLD

Current Price

$0.99

Market Cap

94.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SSBI
ONCY
Founded
1982
1998
Country
United States
Canada
Employees
106
N/A
Industry
Major Banks
Pharmaceuticals and Biotechnology
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
86.7M
94.0M
IPO Year
N/A
2002

Fundamental Metrics

Financial Performance
Metric
SSBI
ONCY
Price
$13.02
$0.99
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$7.33
AVG Volume (30 Days)
3.6K
1.0M
Earning Date
04-28-2026
03-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$13.23
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.60
$0.33
52 Week High
$14.00
$1.51

Technical Indicators

Market Signals
Indicator
SSBI
ONCY
Relative Strength Index (RSI) 47.68 47.72
Support Level $12.73 $0.98
Resistance Level $13.95 $1.08
Average True Range (ATR) 0.25 0.06
MACD -0.03 -0.01
Stochastic Oscillator 32.53 27.51

Price Performance

Historical Comparison
SSBI
ONCY

About SSBI Summit State Bank

Summit State Bank provides various banking products and services to individuals and businesses in Sonoma County, California. It offers personal and business checking, money market, sweep, savings, and demand accounts; time certificates of deposit; and specialized deposit accounts, such as professional, small business packaged, tiered, and retirement plan accounts. The company also provides loans, including commercial loans and leases; lines of credit; commercial real estate, small business administration, residential mortgage, and construction loans; home equity lines of credit; and term and equipment loans, as well as loans to agriculture-related businesses.

About ONCY Oncolytics Biotech Inc.

Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.

Share on Social Networks: